How is the degree of abnormality graded on a positive bubble study for a patent foramen ovale (PFO)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 29, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Grading of PFO Shunt Severity on Bubble Study

The degree of right-to-left shunt on a positive bubble study is graded based on the number of microbubbles appearing in the left atrium, with the most widely used system classifying shunts as: Grade 0 (no bubbles), Grade 1 (small: <20 or <30 bubbles), Grade 2 (moderate: 20-30 to ~25 bubbles or moderate filling), and Grade 3 (large: >25-30 bubbles or complete opacification of the left atrium).

Grading Systems

The evidence reveals two main semi-quantitative grading approaches used in clinical practice and research:

Standard Classification System

The grading is performed during contrast echocardiography (bubble study) with agitated saline:

  • Grade 0: No microbubbles in the left atrium (no shunt)
  • Grade 1: Small shunt with <20-30 microbubbles in the left atrium
  • Grade 2: Moderate shunt with 20-30 bubbles or moderate filling of the left atrium
  • Grade 3: Large shunt with >25-30 microbubbles or complete opacification of the left atrium 1

Clinical Trial Definitions

The major stroke prevention trials used slightly different thresholds but similar concepts:

  • REDUCE trial: Classified shunts as moderate (6-25 microbubbles) or large (>25 microbubbles), with 81% of enrolled patients having moderate or large shunts 2

  • CLOSE trial: Defined a large interatrial shunt as >30 microbubbles in the left atrium within three cardiac cycles after right atrial opacification 2

  • RESPECT trial: Used "substantial" shunt size (grade 3) as a predictor of benefit from closure 2

Technical Considerations

Timing of Bubble Appearance

Critical distinction: Bubbles appearing in the left atrium within 3-4 cardiac cycles after right atrial opacification indicate an intracardiac shunt (PFO or atrial septal defect). Bubbles appearing after 3-8 cardiac cycles suggest an intrapulmonary shunt rather than a PFO 1, 3.

Enhancing Detection

  • Valsalva maneuver transiently increases right atrial pressure and enhances sensitivity for detecting PFO, particularly smaller shunts 4, 5
  • The grading should ideally be performed both at rest and with provocation

Measurement Correlation

When color Doppler is used in addition to contrast, the maximal color Doppler jet width within the atrial septum correlates well with actual PFO diameter (r=0.99) 5.

Clinical Significance of Grading

Higher grades correlate with increased clinical risk:

  • Grades 2 and 3 have positive predictive values of 0.21 and 0.87 respectively for requiring treatment 1
  • Larger shunts are associated with higher rates of cerebral complications 1
  • Patients with large shunts (>25-30 microbubbles) combined with atrial septal aneurysm derive the greatest benefit from PFO closure for stroke prevention 2, 6

Diagnostic Modality Considerations

  • Transthoracic echocardiography (TTE) with contrast: 98-99% sensitivity, 67-91% specificity for detecting PFO 1
  • Transesophageal echocardiography (TEE) with contrast: Considered gold standard with 100% specificity and superior ability to detect mild/moderate shunts 5, 7
  • Transcranial Doppler (TCD): 100% negative predictive value, 92% positive predictive value compared to TEE 8

Common Pitfall

Do not rely on transthoracic echo alone for small shunts: TTE has only 65% negative predictive value and inferior detection of mild/moderate shunts compared to TEE. If clinical suspicion remains high despite negative TTE, proceed to TEE 7.

References

Research

Transthoracic second harmonic two- and three-dimensional echocardiography for detection of patent foramen ovale.

European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology, 2010

Related Questions

In a child with a patent foramen ovale, when should a repeat echocardiogram be performed?
The patient is already on apixaban (Eliquis); could the stroke still be classified as cryptogenic if the possible cause is a patent foramen ovale (PFO) or atrial fibrillation (AF)?
In a 45-year-old male who had a left occipital stroke, a large patent foramen ovale (PFO), and a right lower extremity deep vein thrombosis (DVT) during hospitalization, what components should be included in the cardiac work‑up?
Can a cardiac magnetic resonance imaging (MRI) be performed after closure of a patent foramen ovale (PFO) with a Gore Cardioform device?
Is patent foramen ovale (PFO) closure justified in a patient without a history of stroke, transient ischemic attack, documented paradoxical embolism, or other embolic events?
What is the maximum daily dose of diazepam for seizure control in an adult?
What are the recommended first‑line antiepileptic drug choices, dosing regimens, and monitoring for a child with epilepsy (including focal, generalized tonic‑clonic, and absence seizures), and how should treatment be escalated if seizures persist?
What investigations are indicated for delayed umbilical cord separation (>30 days) in a newborn?
How can I provide home parenteral nutrition for a patient with severe mast‑cell activation syndrome (MCAS) when no home parenteral nutrition (HPN) providers are available?
What does a serum vitamin B12 level of 149 pg/mL indicate and what is the recommended treatment?
Do patients with bilateral nephrostomy tubes continue to void normally?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.